Guardant Health Inc. Stock News

Shares of Guardant Health Inc. GH, +2.50% dropped 9.5% premarket on Wednesday after the company said late Tuesday that a U.S. Food and Drug Administration advisory committee will review its colorectal

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, will present data showing the utility of liquid biopsy tests in the management of breast c

Guardant Health, Inc. (NASDAQ:GH ) Q3 2023 Earnings Conference Call November 6, 2023 4:30 PM ET Company Participants Carrie Mendivil - IR Helmy Eltoukhy - Co-CEO AmirAli Talasaz - Co-CEO Michael Bell

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will report financial results for the third quarter of 2023 af

Guardant Health's various products are all designed to help physicians and patients fight cancer. The company's revenue growth has been good, but its net losses are helping drag down the stock.

Exact Sciences and Guardant Health have both enjoyed triple-digit revenue growth over the past five years. Exact Sciences' shares are up more than 31% so far this year, while Guardant is up a little m

Guardant Health (GH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Analysts at both Bernstein and Piper Sandler had good things to say about Guardant Health this week. Shares of the precision oncology company had plunged more than 35% in September despite a lack of c

Guardant Health stock has lost half its value over the past year. That's the bad news.

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will participate in the upcoming Morgan Stanley 21st Annual Gl

The average of price targets set by Wall Street analysts indicates a potential upside of 42.1% in Guardant Health (GH). While the effectiveness of this highly sought-after metric is questionable, the

Guardant Health's fight against cancer is also proving to be profitable for the company. Pinterest is looking to benefit from e-commerce in addition to its advertising business.

Guardant Health, Inc. (NASDAQ:GH ) Q2 2023 Earnings Conference Call August 3, 2023 4:30 PM ET Company Participants Carrie Mendivil - IR Helmy Eltoukhy - Co-Founder, Co-CEO & Chairman AmirAli Talasaz -

Guardant Health (GH) came out with a quarterly loss of $0.67 per share versus the Zacks Consensus Estimate of a loss of $1.25. This compares to loss of $2.25 per share a year ago.

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will report financial results for the second quarter of 2023 a